Back to search
FDAFDA · Food and drugs·Recall number Z-1069-2013

IMPAX CV 7.8 SU3 - OCR Service. The IMPAX CV Reporting component facilitates the quick , effective creation of digital structured reports for adult catheterization and echocardiography, pediatric echocardiography, congenital heart disease, nuclear cardiology and non-invasive vascular disease management.

Published April 17, 2013 · Recall initiated: March 15, 2013

Summary

FDA records medical device Class II recall Z-1069-2013, published April 17, 2013 and initiated March 15, 2013. Recalling firm: AGFA Corp.; Status: Terminated; Reported quantity: 2; Lot: Softwaer version: IMPAX CR 7.8 SU3 Optical Character Recognition (OCR) Service. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Software design error in IMPAX CV 7.8 SU3

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AGFA Corp.
Distributor
Distribute in the state of FL and KY
Lot
Softwaer version: IMPAX CR 7.8 SU3 Optical Character Recognition (OCR) Service
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was IMPAX CV 7.8 SU3 - OCR Service. The IMPAX CV Reporting component facilitates the quick , effective creation of digital structured reports for adult catheterization and echocardiography, pediatric echocardiography, congenital heart disease, nuclear cardiology and non-invasive vascular disease management. recalled?

Yes. FDA published recall Z-1069-2013 on April 17, 2013. Reported hazard: Software design error in IMPAX CV 7.8 SU3

What should I do if I have this product?

Voluntary: Firm initiated · Letter